Exenatide treatment exerts anxiolytic- and antidepressant-like effects and reverses neuropathy in a mouse model of type-2 diabetes

Medical science monitor basic research

Volumn 20, Issue , 2014, Pages 112-117

  Komsuoglu Celikyurt, Ipek ^a   Mutlu, Oguz ^a   Ulak, Guner ^a   Uyar, Emre ^a   Bektaş, Emine ^a   Yildiz Akar, Furuzan ^a   Erden, Faruk ^a   Tarkun, Ilhan ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; EXENDIN 4; PEPTIDE; VENOM;

ANIMAL; BAGG ALBINO MOUSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE MODEL; DRUG EFFECTS; IMMOBILIZATION; MALE; MAZE TEST; MOTOR ACTIVITY; PATHOPHYSIOLOGY; REACTION TIME; TIME;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; IMMOBILIZATION; MALE; MAZE LEARNING; MICE, INBRED BALB C; MOTOR ACTIVITY; PEPTIDES; REACTION TIME; TIME FACTORS; VENOMS;

EID: 84919448750     PISSN: None     EISSN: 23254416     Source Type: Journal    
DOI: 10.12659/MSMBR.891168     Document Type: Article

References (0)